Hos patienter med mildt til moderat nedsat nyrefunktion (GFR ≥ 30 ml/ min/ 1, 73 m2, men < 60 ml/ min/ 1, 73 m2), skal Rasilez HCT imidlertid gives med forsigtighed.
However, in patients with mild to moderate renal impairment (GFR ≥ 30 ml/ min/ 1.73 m2 but < 60 ml/ min/ 1.73 m2), Rasilez HCT should be administered with caution.